Agathos,
You are right. Bio is a speculative stock and big risk -anything can happen.
Do you know last year only less than 15 drugs are approve by FDA. 2 ovarian phase 3 trials were abandon ( 1 by lilly and other i forgot).
Be very careful. I have be following PRR since inception and only by the stock 2 years ago after reading Fortrend is willing to finance PRR 12 million by convertble. I believe this is still in place but prr has not taken the offer and 3 moinths later springtree came to the picture.
Agathos,You are right. Bio is a speculative stock and big risk...
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.015(5.36%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.0¢ | $833.4K | 2.824M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 388130 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 39940 | 3 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |